AUTO-INJECTORS MARKET ANALYSIS

Market Challenges And Opportunities

Global Auto-injectors Market - Driver

Increasing inorganic strategies such as agreement is expected to boost the growth of global auto-injectors market. For instance, in May 2022, Stevanato Group, a manufacturer and distributor of drug containment, announced that they had signed an agreement with Owen Mumford Ltd., a manufacturer of medical device, for its Aidaptus auto-injector. This agreement will bring value to customers, matching world-class device expertise with premium manufacturing capabilities. Aidaptus auto-injector is a two-step, single use auto-injector with a versatile design that accommodates both 1 mL and 2.25 mL prefilled glass syringes in the same base device.

Auto-injectors Market Report Coverage

Growth Drivers:	Adoption of inorganic strategies such as product launch and agreement by key market players
Restraints & Challenges:	Increasing number of product recalls by regulatory authorities such as U.S. Food and Drug Administration

Global Auto-injectors Market: Restraint

Increasing number of product recalls by regulatory authorities such as the U.S. Food and Drug Administration. For instance, in September 2021, a trulicity auto-injector, which is manufactured by Eli Lilly & Company, a pharmaceutical company, was recalled by the U.S. Food and Drug Administration due to labelling error. The auto-injector device was labeled as 0.75 mg/0.5 mL as it was actually contained 1.5 mg/0.5 mL of product. The recall affects 119,539 boxes of Trulicity 0.75 mg/0.5 mL single-dose pens, four pens per box (NDC 0002-1433-80), from lot D396436C.